GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,509.20p
   
  • Change Today:
      12.40p
  • 52 Week High: 1,722.00
  • 52 Week Low: 1,242.80
  • Currency: UK Pounds
  • Shares Issued: 4,959.30m
  • Volume: 8,618,302
  • Market Cap: 74,846m
  • RiskGrade: 96

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.3% 5.4%
Div Cover 1.4 1.3
Op Mrgn 13.5% 24.3%
ROCE n/a  
Latest F'cast
P/E 13.5 14.1
PEG 1.5 n/a
Pr/Revenue 2.5 2.5
Pr/Book 21.5  
Latest F'cast
Revenue 8.2% -1.2%
PBT 81.8% 105.3%
EPS 9.2% -4.6%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 29,818.81 7,237.48 106.70p 14.1 n/a -5% 80.00p 5.4%
31-Dec-19 30,522.19 7,493.13 111.93p 13.5 2.8 +5% 80.13p 5.4%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

ViiV granted EU marketing authorisation for Juluca 21-May-2018 11:02 RNS
Director/PDMR Shareholding 15-May-2018 13:39 RNS
Director/PDMR Shareholding 11-May-2018 15:17 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
10-May-18 Buy Victoria Whyte 1,466.64p 9 132.00
10-May-18 Transfer From David Redfern 0.000p 9 0.00
10-May-18 Transfer From Simon Dingemans 0.000p 9 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,509.20p
Change Today 12.40p
% Change 0.83 %
52 Week High 1,722.00
52 Week Low 1,242.80
Volume 8,618,302
Shares Issued 4,959.30m
Market Cap 74,846m
RiskGrade 96

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.48% below the market average26.48% below the market average26.48% below the market average26.48% below the market average26.48% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
12.99% above the market average12.99% above the market average12.99% above the market average12.99% above the market average12.99% above the market average
3.12% above the sector average3.12% above the sector average3.12% above the sector average3.12% above the sector average3.12% above the sector average
Income
79.38% above the market average79.38% above the market average79.38% above the market average79.38% above the market average79.38% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
35.41% above the market average35.41% above the market average35.41% above the market average35.41% above the market average35.41% above the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

What The Brokers Say

Strong Buy 9
Buy 2
Neutral 14
Sell 0
Strong Sell 2
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 10-May-18 22-Feb-18
Paid 12-Jul-18 12-Apr-18
Amount 19.00p 23.00p

Trades for 22-May-2018

Time Volume / Share Price
17:08 3,673 @ 1,512.25p
16:55 76,214 @ 1,508.95p
16:54 700 @ 1,510.80p
16:54 1,661 @ 1,508.81p
16:53 175 @ 1,510.40p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page